SCHEMBL15940233

SCHEMBL15940233

CCOC(CCNc1nc(-c2sc(CC(N)=O)nc2C)cs1)OCC

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 4/20 0.69
PI4KB Q9UBF8 6/20 0.46
MAPT P10636 6/20 0.46
HTT P42858 3/20 0.46
KDM4E B2RXH2 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ALDH1A1 P00352 5/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
TDP1 Q9NUW8 2/20 0.42
NPC1 O15118 1/20 0.42
HSD17B10 Q99714 2/20 0.41
GAA P10253 2/20 0.41
USP2 O75604 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
OPRM1 P35372 1/20 0.41
NPY5R Q15761 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4523629 0.82 PIK3CG (1.00) PIK3CGPI4KBMAPTHTTKDM4E
SCHEMBL15940389 0.77 PIK3CG (0.58) PIK3CGPI4KBMAPTHTTKDM4E
SCHEMBL2835239 0.77 PIK3CG (0.64) PIK3CGPI4KBMAPTHTTKDM4E
SCHEMBL15940392 0.74 MAPT (0.55) PIK3CGPI4KBMAPTHTTKDM4E
SCHEMBL15940355 0.73 PIK3CG (0.47) PIK3CGPI4KBMAPTHTTKDM4E
SCHEMBL4531912 0.71 PIK3CG (0.81) PIK3CGPI4KBMAPTHTTKDM4E
SCHEMBL15940390 0.70 MEN1 (0.53) MAPTHTTKDM4ESMN1; SMN2LMNA
SCHEMBL5427675 0.68 PIK3CG (1.00) PIK3CGPI4KBMAPTHTTKDM4E
SCHEMBL15940334 0.66 MEN1 (0.55) PIK3CGMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL2840142 0.66 PIK3CG (0.69) PIK3CGPI4KBMAPTHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140228365-A1 THIAZOLE DERIVATIVES AND USE THEREOF MERCK SERONO S.A. (CH) 2014-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140228365-A1 THIAZOLE DERIVATIVES AND USE THEREOF PF4, TEC, PDGFRB PIK3CG 2806/4885PI4KB 2458/4885MAPT 4151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.